tiprankstipranks
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR

X4 Pharmaceuticals (XFOR) Income Statement

720 Followers

X4 Pharmaceuticals Income Statement

Last quarter (Q3 2023), X4 Pharmaceuticals's total revenue was $49.00K, an increase of Infinity% from the same quarter last year. In Q3, X4 Pharmaceuticals's net income was $-2.31M. See X4 Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 244.00K-$ 196.00K$ 3.00M$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 244.00K-$ 196.00K---
Operating Expense
$ 107.90M$ 87.57M$ 75.35M$ 62.87M$ 47.80M$ 29.09M
Operating Income
$ -107.90M$ -87.57M$ -75.35M$ -59.87M$ -47.80M$ -29.09M
Net Non Operating Interest Income Expense
$ 3.74M$ -3.77M$ -3.63M$ -2.42M$ -950.00K$ -484.00K
Other Income Expense
$ 2.23M$ 1.99M$ -60.00K$ 306.00K$ -4.05M$ -3.72M
Pretax Income
$ -111.08M$ -93.84M$ -88.68M$ -61.98M$ -52.81M$ -33.28M
Tax Provision
$ 59.00K$ 28.00K$ 17.00K$ 148.00K$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
$ -176.00K-----
Net Income Common Stockholders
$ -111.14M$ -96.41M$ -102.64M$ -62.13M$ -53.40M$ -36.31M
Basic EPS
$ -1.76$ -1.52$ -3.99$ -3.09$ -4.63$ -79.15
Diluted EPS
$ -0.44$ -1.52$ -3.99$ -3.09$ -4.63$ -79.15
Basic Average Shares
$ 575.22M$ 63.53M$ 25.75M$ 20.08M$ 11.53M$ 459.00K
Diluted Average Shares
$ 575.22M$ 63.53M$ 25.75M$ 20.08M$ 11.53M$ 459.00K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
---$ 0.20--
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 107.90M$ 87.57M$ 75.35M$ 62.87M$ 47.80M$ 29.09M
Net Income From Continuing And Discontinued Operation
$ -111.14M$ -93.87M$ -88.70M$ -62.13M$ -52.81M$ -33.28M
Normalized Income
$ -46.80M$ -74.13M-$ -61.69M$ -48.24M$ -29.57M
Interest Expense
---$ 2.69M$ 2.15M$ 720.00K
EBIT
$ -112.52M$ -89.85M$ -85.05M$ -59.30M$ -50.66M$ -32.56M
EBITDA
$ -28.02M$ -89.33M$ -84.55M$ -58.94M$ -50.56M$ -32.46M
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis